Related Experiment Video
Updated: Feb 16, 2026

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
Bacterial meningitis antibiotic treatment
1Groupe de Pathologie Infectieuse Pédiatrique (GPIP) de la Société française de pédiatrie, Saint Maur des Fossés, France; ACTIV (Association Clinique et Thérapeutique Infantile du Val de Marne), 27 rue Inkermann, 94100 Saint-Maur des Fossés, France; Université Paris Est, IMRB- GRC GEMINI, 94000 Créteil, France; Centre de Recherche Clinique (CRC) et Centre Hospitalier Intercommunal (CHI), 40 avenue de Verdun, 94010 Créteil, France; Unité Court Séjour, Petits Nourrissons, Service de Néonatologie, Centre Hospitalier Intercommunal de Créteil (CHI), 40 avenue de Verdun, 94010 Créteil, France.
Pneumococcal conjugate vaccines have eliminated meningitis caused by cephalosporin-resistant pneumococcus. Initial vancomycin treatment for pneumococcal meningitis is no longer recommended, reserving it for resistant cases.
Area of Science:
- Pediatric Infectious Diseases
- Bacteriology
- Vaccinology
Background:
- Pneumococcal conjugate vaccines (PCVs) were introduced in 2010-2011.
- PCVs have altered the epidemiology of pneumococcal meningitis.
Purpose of the Study:
- To evaluate the impact of PCVs on pneumococcal meningitis resistance patterns.
- To update treatment guidelines for pneumococcal and meningococcal meningitis.
Main Methods:
- Analysis of data from the National Pediatric Meningitis Network (over 15 years).
- Monitoring of antibiotic susceptibility of pneumococcal and meningococcal strains.
Main Results:
- No cases of meningitis due to pneumococcus resistant to third-generation cephalosporins (3GC) reported in the last 3 years.
- All meningococcal meningitis strains remain susceptible to 3GC, though some show reduced susceptibility to penicillin and amoxicillin.
Conclusions:
- Vancomycin is not recommended for initial treatment of suspected or confirmed pneumococcal meningitis.
- Vancomycin should be reserved for cases with 3GC minimum inhibitory concentration > 0.5mg/L.
- Continued surveillance is crucial for adapting treatment strategies to evolving resistance patterns.
Related Concept Videos
Antibiotic Selection
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Development of Antibiotic Resistance
Bacterial Signaling
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...

